文献速递神经肿瘤

脑膜瘤呈现特定的免疫表达模式并呈头尾梯度:366例患者分析

Meningiomas Display a Specific Immunoexpression Pattern in a Rostrocaudal Gradient: An Analysis of 366 Patients.
PubMed 文献 · World Neurosurg · 2018-11-29

回顾性分析2003至2016年366例脑膜瘤患者,检测EMA、PR、CD34、S100、p53和Ki-67标记指数,发现EMA+PR+S100-模式在颅顶(30.3%)显著低于颅底(45.89%,P=0.021),p53表达与Ki-67和WHO分级正相关,PR阳性与S100、p53、Ki-67和WHO分级负相关,提示脑膜瘤生物学存在头尾梯度。

要点

  • EMA、PR、S100、p53和CD34在肿瘤中表达率分别为94%、73%、49%、26%和23%。
  • p53表达与Ki-67和WHO分级正相关(rτ=0.31和rτ=0.4)。
  • EMA+PR+S100-比例颅顶30.3%低于颅底45.89%(P=0.021)。

核心结论

  • 无监督方法检测到脑膜瘤解剖位置与肿瘤生物学之间的关联,研究揭示颅顶和颅底均存在头尾梯度,与人类发育生物学相关。

研究设计与样本

  • 回顾性分析2003至2016年366例脑膜瘤患者的病历资料,检测6种标记物:上皮膜抗原(EMA)、孕激素受体(PR)、CD34、S100、p53和Ki-67标记指数。

主要发现

  • EMA、PR、S100、p53和CD34在肿瘤中的表达率分别为94%、73%、49%、26%和23%。
  • p53表达与Ki-67和WHO分级正相关(rτ=0.31和rτ=0.4)。
  • PR阳性与S100、p53、Ki-67和WHO分级负相关(rτ=-0.19、rτ=-0.14、rτ=-0.15和rτ=-0.16)。
  • 所有分泌型脑膜瘤均EMA和PR阳性、S100阴性,该模式呈头尾梯度。
  • EMA+PR+S100-病例总体比例颅顶(30.3%)显著低于颅底(45.89%;P=0.021);WHO II-III级肿瘤比例颅顶高于颅底。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Meningiomas are heterogeneous, with differences in anatomical, histopathological, and clinical characteristics. Such spatial variability in meningioma biology is thought to result from differences in the expression of critical developmental regulators. We hypothesized that the variability in meningioma biology would follow gradients such as in embryology and tested a cohort of 366 meningiomas for histopathological and immunohistochemical gradients. METHODS: The medical records from 366 patients treated for meningiomas from 2003 to 2016 were retrospectively analyzed for age, gender, anatomical localization, recurrence-free survival, overall survival, histopathological diagnosis, and immunohistochemistry findings for 6 markers: epithelial membrane antigen (EMA), progesterone receptor (PR), CD34, S100, p53, and Ki-67 labeling index. RESULTS: EMA, PR, S100, p53, and CD34 were expressed in 94%, 73%, 49%, 26%, and 23% of the tumors, respectively. p53 expression correlated positively with Ki-67 and World Health Organization (WHO) grade (rτ = 0.31 and rτ = 0.4, respectively). PR positivity correlated inversely with S100, p53, Ki-67, and WHO grade (rτ = -0.19, rτ = -0.14, rτ = -0.15, and rτ = -0.16, respectively). All secretory meningiomas were positive for EMA and PR and negative for S100, and this pattern exhibited a rostrocaudal gradient. The overall proportion of EMA+PR+S100- cases was significantly lower in the cranial vault (30.3%) than in the skull base (45.89%; P = 0.021). The proportion of WHO grade II-III tumors was greater in cranial vault than in skull base meningiomas. CONCLUSIONS: Unsupervised methods detected an association between the anatomical location and tumor biology in meningiomas. Unlike the categorical associations that former studies had indicated, the present study revealed a rostrocaudal gradient in both the cranial vault and the skull base, correlating with human developmental biology.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ülgen E, Bektaşoğlu PK, Sav MA, et al. Meningiomas Display a Specific Immunoexpression Pattern in a Rostrocaudal Gradient: An Analysis of 366 Patients. World Neurosurg. 2018. PMID: 30503291. doi:10.1016/j.wneu.2018.11.201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。